N. Luebke

Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany

T. Luedde, A. Dilthey, V. Keitel, 2021, The Lancet Regional Health - Europe.

Screening for SARS-CoV-2 infections in daycare facilities for children in a large city in Germany

L. Ehlkes, R. Brinks, O. Adams, 2021, medRxiv.

High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection

C. Sarrazin, J. Rockstroh, S. Mauss, 2018, Alimentary pharmacology & therapeutics.

How Individual Can Personalized Antiretroviral Treatment Be? Deep Salvage in an HIV-1-Infected Patient

R. Kaiser, D. Häussinger, S. Esser, 2012, Intervirology.

Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients

T. Luedde, A. Dilthey, J. Bode, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.